Noninvasive monitoring in a patient with SAH diagnosis treated with Cerebrolysin – case report and review of the literature

K. Kojder, K. Jarosz, A. Andrzejewska, K. Kubiak, W. Poncyljusz, J. Sołek-Pastuszka

Anesthesiology and Intensive Care Department, Pomeranian Medical University, Szczecin, Poland. klaudyna.kojder@pum.edu.pl

---

• Neurology

BACKGROUND: Subarachnoid hemorrhage (SAH) causes a high percentage of deaths and rehabilitation failures. Despite endovascular and surgery treatment algorithms, there is still no consensus on the guidelines for monitoring and neuroprotective treatment of patients.

CASE REPORT: We report a case of a patient with SAH treated endovascularly. The patient was hospitalized in the intensive care unit and monitored using Near Infrared Spectroscopy (NIRS) and Optic Nerve Diameters Assessment (ONDS).

CONCLUSIONS: Early and high-dose Cerebrolysin was used safely as neuroprotective treatment intravenously. The treatment using Cerebrolysin and additional monitoring was beneficial for the patient.

Free PDF Download